Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial
Bristol-Myers Squibb
Robert J Motzer; Axel Bex; Paul Russo; Yoshihiko Tomita; Hernan Javier Cutuli; Carlos Rojas; Marine Gross-Goupil; Giovanni Schinzari; Bohuslav Melichar; Philippe Barthélémy; Abraham Ruiz Garcia; Jeffrey Sosman; Marc-Oliver Grimm; Jeffrey C Goh; Cristina Suarez; Christian K Kollmannsberger; Suresh G Nair; Brian M Shuch; Jian Huang; Burcin Simsek; Julia Spiridigliozzi; Chung-Wei Lee; Maximiliano van Kooten Losio; Viktor Grünwald